High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells

ABSTRACT: Regulatory T cells (Tregs ) modulate the magnitude of immune responses and possess therapeutic potential in an array of immune diseases. Statins reduce the activation and proliferation of conventional T cells (Tcons ), and they seem to up-regulate the frequency and function of Tregs . Howe...

Full description

Autores:
Rodríguez Perea, Ana Lucía
Rojas López, Mauricio
Velilla Hernández, Paula Andrea
Tipo de recurso:
Article of investigation
Fecha de publicación:
2019
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/32160
Acceso en línea:
https://hdl.handle.net/10495/32160
Palabra clave:
Antígenos CD
Antigens, CD
Atorvastatina
Atorvastatin
Antígeno CTLA-4
CTLA-4 Antigen
Células Cultivadas
Cells, Cultured
Citocinas
Cytokines
Citometría de Flujo
Flow Cytometry
Factores de Transcripción Forkhead
Forkhead Transcription Factors
Interleucina-2
Interleukin-2
Linfocitos T Reguladores
T-Lymphocytes, Regulatory
Factor de Necrosis Tumoral alfa
Tumor Necrosis Factor-alpha
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_749c5b8fa2d82d45ff75a08e30ca7e20
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/32160
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
title High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
spellingShingle High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
Antígenos CD
Antigens, CD
Atorvastatina
Atorvastatin
Antígeno CTLA-4
CTLA-4 Antigen
Células Cultivadas
Cells, Cultured
Citocinas
Cytokines
Citometría de Flujo
Flow Cytometry
Factores de Transcripción Forkhead
Forkhead Transcription Factors
Interleucina-2
Interleukin-2
Linfocitos T Reguladores
T-Lymphocytes, Regulatory
Factor de Necrosis Tumoral alfa
Tumor Necrosis Factor-alpha
title_short High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
title_full High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
title_fullStr High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
title_full_unstemmed High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
title_sort High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells
dc.creator.fl_str_mv Rodríguez Perea, Ana Lucía
Rojas López, Mauricio
Velilla Hernández, Paula Andrea
dc.contributor.author.none.fl_str_mv Rodríguez Perea, Ana Lucía
Rojas López, Mauricio
Velilla Hernández, Paula Andrea
dc.contributor.researchgroup.spa.fl_str_mv Bacterias & Cáncer
Grupo de Inmunología Celular e Inmunogenética
Inmunovirología
dc.subject.decs.none.fl_str_mv Antígenos CD
Antigens, CD
Atorvastatina
Atorvastatin
Antígeno CTLA-4
CTLA-4 Antigen
Células Cultivadas
Cells, Cultured
Citocinas
Cytokines
Citometría de Flujo
Flow Cytometry
Factores de Transcripción Forkhead
Forkhead Transcription Factors
Interleucina-2
Interleukin-2
Linfocitos T Reguladores
T-Lymphocytes, Regulatory
Factor de Necrosis Tumoral alfa
Tumor Necrosis Factor-alpha
topic Antígenos CD
Antigens, CD
Atorvastatina
Atorvastatin
Antígeno CTLA-4
CTLA-4 Antigen
Células Cultivadas
Cells, Cultured
Citocinas
Cytokines
Citometría de Flujo
Flow Cytometry
Factores de Transcripción Forkhead
Forkhead Transcription Factors
Interleucina-2
Interleukin-2
Linfocitos T Reguladores
T-Lymphocytes, Regulatory
Factor de Necrosis Tumoral alfa
Tumor Necrosis Factor-alpha
description ABSTRACT: Regulatory T cells (Tregs ) modulate the magnitude of immune responses and possess therapeutic potential in an array of immune diseases. Statins reduce the activation and proliferation of conventional T cells (Tcons ), and they seem to up-regulate the frequency and function of Tregs . However, there is a lack of simultaneous evaluation of the in-vitro effect of statins on the functional profile of Tregs versus Tcons . Herein, magnetically purified Tcons and Tregs were stimulated with CD3/CD28/interleukin (IL)-2 in the presence of atorvastatin (ATV) at 1 or 10 µM. The suppressive function of Tregs , the expression of markers associated with Treg function, activation levels, cytokine production and calcium flux in both subpopulations were assessed by flow cytometry. ATV had no cytotoxic effect on T cells at the concentrations used. Interestingly, 10 µM ATV hampered the suppressive capacity of Tregs . Moreover, this higher concentration reduced the expression of forkhead box protein 3 (FoxP3), cytotoxic T lymphocyte antigen (CTLA-4) and programmed death 1 (PD-1). In Tcons , ATV at 10 µM decreased PD-1 and CD45RO expression. The expression of CD25, CD69, CD95, CD38, CD62L, CCR7 and perforin was not affected in both subpopulations or at any ATV concentrations. Remarkably, 10 µM ATV increased the percentage of tumour necrosis factor (TNF)-α-producing Tregs . Although there was a reduction of calcium flux in Tcons and Tregs , it was only significant in 10 µM ATV-treated Tcons . These results suggested that 10 µM ATV affects the cellular functions of both populations; however, this concentration particularly affected several aspects of Treg biology: its suppressive function, cytokine production and expression of Treg -specific markers.
publishDate 2019
dc.date.issued.none.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2022-11-21T13:54:22Z
dc.date.available.none.fl_str_mv 2022-11-21T13:54:22Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Rodríguez-Perea AL, Rojas M, Velilla-Hernández PA. High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells. Clin Exp Immunol. 2019 May;196(2):237-248. doi: 10.1111/cei.13260.
dc.identifier.issn.none.fl_str_mv 0009-9104
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/32160
dc.identifier.doi.none.fl_str_mv 10.1111/cei.13260.
dc.identifier.eissn.none.fl_str_mv 1365-2249
identifier_str_mv Rodríguez-Perea AL, Rojas M, Velilla-Hernández PA. High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells. Clin Exp Immunol. 2019 May;196(2):237-248. doi: 10.1111/cei.13260.
0009-9104
10.1111/cei.13260.
1365-2249
url https://hdl.handle.net/10495/32160
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Clin Exp Immunol
dc.relation.citationendpage.spa.fl_str_mv 248
dc.relation.citationissue.spa.fl_str_mv 2
dc.relation.citationstartpage.spa.fl_str_mv 237
dc.relation.citationvolume.spa.fl_str_mv 196
dc.relation.ispartofjournal.spa.fl_str_mv Clinical and Experimental Immunology
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 12 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv British Society for Immunology
dc.publisher.place.spa.fl_str_mv Oxford, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/45113322-2bcd-4b4b-a58b-9db861d22b7d/download
https://bibliotecadigital.udea.edu.co/bitstreams/f2992efb-d197-4e9b-a8be-64361da43a8c/download
https://bibliotecadigital.udea.edu.co/bitstreams/507831d5-c34b-4451-be4b-35d3d80e12a9/download
https://bibliotecadigital.udea.edu.co/bitstreams/aafa1887-a0e2-43e1-9b4e-202d42df5a70/download
https://bibliotecadigital.udea.edu.co/bitstreams/5e717b4a-dbe1-406e-91c8-136e7ce5805f/download
bitstream.checksum.fl_str_mv c47d5a7216f5653313d2ceb664729175
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
6fe6335e2ad7d2c406237d31101defba
fd9db23e2d69c4501c56fb4e87ba9afc
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052184971509760
spelling Rodríguez Perea, Ana LucíaRojas López, MauricioVelilla Hernández, Paula AndreaBacterias & CáncerGrupo de Inmunología Celular e InmunogenéticaInmunovirología2022-11-21T13:54:22Z2022-11-21T13:54:22Z2019Rodríguez-Perea AL, Rojas M, Velilla-Hernández PA. High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells. Clin Exp Immunol. 2019 May;196(2):237-248. doi: 10.1111/cei.13260.0009-9104https://hdl.handle.net/10495/3216010.1111/cei.13260.1365-2249ABSTRACT: Regulatory T cells (Tregs ) modulate the magnitude of immune responses and possess therapeutic potential in an array of immune diseases. Statins reduce the activation and proliferation of conventional T cells (Tcons ), and they seem to up-regulate the frequency and function of Tregs . However, there is a lack of simultaneous evaluation of the in-vitro effect of statins on the functional profile of Tregs versus Tcons . Herein, magnetically purified Tcons and Tregs were stimulated with CD3/CD28/interleukin (IL)-2 in the presence of atorvastatin (ATV) at 1 or 10 µM. The suppressive function of Tregs , the expression of markers associated with Treg function, activation levels, cytokine production and calcium flux in both subpopulations were assessed by flow cytometry. ATV had no cytotoxic effect on T cells at the concentrations used. Interestingly, 10 µM ATV hampered the suppressive capacity of Tregs . Moreover, this higher concentration reduced the expression of forkhead box protein 3 (FoxP3), cytotoxic T lymphocyte antigen (CTLA-4) and programmed death 1 (PD-1). In Tcons , ATV at 10 µM decreased PD-1 and CD45RO expression. The expression of CD25, CD69, CD95, CD38, CD62L, CCR7 and perforin was not affected in both subpopulations or at any ATV concentrations. Remarkably, 10 µM ATV increased the percentage of tumour necrosis factor (TNF)-α-producing Tregs . Although there was a reduction of calcium flux in Tcons and Tregs , it was only significant in 10 µM ATV-treated Tcons . These results suggested that 10 µM ATV affects the cellular functions of both populations; however, this concentration particularly affected several aspects of Treg biology: its suppressive function, cytokine production and expression of Treg -specific markers.COL0012444COL0008639COL007045712 páginasapplication/pdfengBritish Society for ImmunologyOxford, Inglaterrahttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cellsArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAntígenos CDAntigens, CDAtorvastatinaAtorvastatinAntígeno CTLA-4CTLA-4 AntigenCélulas CultivadasCells, CulturedCitocinasCytokinesCitometría de FlujoFlow CytometryFactores de Transcripción ForkheadForkhead Transcription FactorsInterleucina-2Interleukin-2Linfocitos T ReguladoresT-Lymphocytes, RegulatoryFactor de Necrosis Tumoral alfaTumor Necrosis Factor-alphaClin Exp Immunol2482237196Clinical and Experimental ImmunologyPublicationORIGINALRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdfRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdfArtículo de investigaciónapplication/pdf939879https://bibliotecadigital.udea.edu.co/bitstreams/45113322-2bcd-4b4b-a58b-9db861d22b7d/downloadc47d5a7216f5653313d2ceb664729175MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/f2992efb-d197-4e9b-a8be-64361da43a8c/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/507831d5-c34b-4451-be4b-35d3d80e12a9/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdf.txtRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdf.txtExtracted texttext/plain45010https://bibliotecadigital.udea.edu.co/bitstreams/aafa1887-a0e2-43e1-9b4e-202d42df5a70/download6fe6335e2ad7d2c406237d31101defbaMD56falseAnonymousREADTHUMBNAILRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdf.jpgRodríguezAna_2019_AtorvastatinRegulatoryTCells.pdf.jpgGenerated Thumbnailimage/jpeg16041https://bibliotecadigital.udea.edu.co/bitstreams/5e717b4a-dbe1-406e-91c8-136e7ce5805f/downloadfd9db23e2d69c4501c56fb4e87ba9afcMD57falseAnonymousREAD10495/32160oai:bibliotecadigital.udea.edu.co:10495/321602025-03-26 18:14:56.251https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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